PostYou are now at: Home » Products » Chemicals » Chemical Waste »

Melanotan II Raw Powder for Sexual Impotence and Skin Cancer

Click image to view original image
Brand: Guangzhouquanao
型号: skype;Candice148722
Price: Negotiable
Min.Order:
Supply
Delivery: Shipment within 3 days since the date of payment
Address: China
Valid until: 2032-11-03
Updated on: 2015-06-02 11:06
Hits: 2684827
Enquiry
Company Detail
 
 
Details
 Melanotan II Raw Powder for Sexual Impotence and Skin Cancer
skype;Candice148722 

whatsApp:8618038176817

if you are interested in my products,pls contact me,thanks 

competitive advantage :

Product Name:Melanotan II,Melanotan II split into vivals,Melanotan II supplier,Melanotan II manufacturer
Another Name:Melanotan II; AC-NLE-CYCLO(-BETA-ASP-HIS-D-PHE-ARG-TRP-EPSILON-LYS-NH2);
CAS:121062-08-6
MW:1024.18
MF:C50H69N15O9
Assay:99%
Package:1g/bottle
Appearance:white solid powder
Product Description:
Introduction:Main treatment: Sexual impotence, skin cancer.
During the research, people found the side effects of Melanotan II that has black skin, enhance the vitality and suppress the appetite, so, although Meilanuotan not through the America food and Drug Administration approval, but it has been a lot of women abused as a weight loss drug.Melanotan II.
The Development of Melanotan 2
The initial creation of the synthetic Melanotan 2 peptide can be credited to the University of Arizona. During the course of research aimed at developing a defense against skin cancer, focus was placed on developing a method of stimulating natural melanogenesis, or the natural production of melanin in the skin, without direct exposure to the potentially harmful ultraviolet radiation in sunlight. Initially, University of Arizona researchers attempted to directly administer the naturally occurring hormone alpha-MSH in order to elicit this desired result. Although this strategy exhibited promising results
Total: 0 [Show All]  Related Reviews
 
More »Our Others Products

[ ProductsSearch ]  [ Add To Favourite ]  [ Tell Friends ]  [ Print Content ]  [ Violation Report ]  [ Close Window ]